LFCR
Lifecore Biomedical, Inc. \De\Company with tickers: LFCR
CIK
1005286
CUSIP
514766104
Shares Outstanding
37,509,407
13F Activity (30d)
91 filings
91 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | $4,462,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Expenses | — | ||||
| Research & Development | $1,217,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $-4,672,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $-14,980,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $-0.43 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $-0.43 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |